The integration of cancer biomarkers allowing remarkable advancements in cancer therapeutics

Jean-Charles Soria shared a post on Linkedin:

” The integration of cancer biomarkers has revolutionized cancer treatment, allowing remarkable advancements in cancer therapeutics and the prognosis of cancer patients. This review paints the road ahead.”

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment

Authors: Antonio Passaro, Maise Al Bakir, Emily G. Hamilton, Maximilian Diehn, Fabrice Andre, Sinchita Roy-Chowdhuri, Giannis Mountzios, Ignacio I. Wistuba, Charles Swanton, Solange Peters.

Source: Jean-Charles Soria/Linkedin

Jean-Charles Soria serves as Amgen’s senior vice president of Oncology within Global Development. He is a medical oncologist and a professor of medicine at Paris-Saclay University. From 2017 to 2019, he was the senior vice president of Research and Development in Oncology at AstraZeneca. Additionally, Soria has authored or co-authored over 670 articles in leading international journals and has been recognized as one of the world’s most influential research scientists.